Browse By Cell Line Result Page of OvirusTdb

The total number of records retrieved from this search are 150. Click on ID to see further detail.
IDVirus nameVirus strainVirus genome typeVirus familyVirus genome modificationVirus aloneVirus in combination with drug/radiationImmune gene insertion in viral genomeSource of cell lineOrigin of cell lineCell lineConcentration of cell lineIn-vitro toxicityAssayIn-vitro virus concentrationIn-vitro resultModel organismIn-vivo virus concentrationIn-vivo toxicityIn-vivo resultMode of deliveryPathway inducedImmunogenic effectClinical trialPMID
OV_568AlphavirusM1RNATogaviridaeNoneNoViral strain in combination with PKA catalytic subunit siRNA and scramble siRNA (siPKA-1)NoATCCHuman colorectal carcinoma cell lineHCT-1164000 cells per wellNAMTT assay10 PFU/cell62% cancer cell viability at 72 hours post-infectionNoNoNA No responseNANANANA27374176
OV_569AlphavirusM1RNATogaviridaeNoneNoViral strain in combination with PKA catalytic subunit siRNA and scramble siRNA (siPKA-2)NoATCCHuman colorectal carcinoma cell lineHCT-1164000 cells per wellNAMTT assay10 PFU/cell57% cancer cell viability at 72 hours post-infectionNoNoNA No responseNANANANA27374176
OV_570AlphavirusM1RNATogaviridaeNoneNoViral strain in combination with PKA catalytic subunit siRNA and scramble siRNA (siPKA-3)NoATCCHuman colorectal carcinoma cell lineHCT-1164000 cells per wellNAMTT assay10 PFU/cell65% cancer cell viability at 72 hours post-infectionNoNoNA No responseNANANANA27374176
OV_571AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman colorectal carcinoma cell lineHCT-1164000 cells per wellNAMTT assay10 PFU/cell50% cancer cell viability at 72 hours post-infectionNoNoNA No responseNANAM1 upregulated transcriptional ISGs (329 shown here)NA27374176
OV_572AlphavirusM1RNATogaviridaeNoneNoViral strain in combination with H89(10 μM) for 1 hourNoATCCHuman colorectal carcinoma cell lineHCT-1164000 cells per wellVery small toxicity towards human immortalized liver cell line L-02MTT assay0.001 PFU/cell70% cancer cell viability at 72 hours post-infectionNoNoNA No responseNAJNK, mitochondrial apoptotic pathway, Caspase-3/7, Caspase-9 and Caspase-8 (active caspases activates downstream apoptotic pathway) are activatedM1 upregulated transcriptional ISGs (329 shown here) were inhibited by H89NA27374176
OV_573AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman colorectal carcinoma cell lineHCT-1164000 cells per wellNon toxic to human immortalized liver cell line L-02MTT assay0.001 PFU/cell100% cancer cell viability at 72 hours post-infectionNoNoNA No responseNANAM1 upregulated transcriptional ISGs (329 shown here)NA27374176
OV_574AlphavirusM1RNATogaviridaeNoneNoViral strain in combination with H89(10 μM) for 1 hourNoATCCHuman colorectal carcinoma cell lineHCT-1164000 cells per wellVery small toxicity towards human immortalized liver cell line L-02MTT assay0.01 PFU/cell39% cancer cell viability at 72 hours post-infectionNoNoNA No responseNAJNK, mitochondrial apoptotic pathway, Caspase-3/7, Caspase-9 and Caspase-8 (active caspases activates downstream apoptotic pathway) are activatedM1 upregulated transcriptional ISGs (329 shown here) were inhibited by H89NA27374176
OV_575AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman colorectal carcinoma cell lineHCT-1164000 cells per wellNon toxic to human immortalized liver cell line L-02MTT assay0.01 PFU/cell100% cancer cell viability at 72 hours post-infectionNoNoNA No responseNANAM1 upregulated transcriptional ISGs (329 shown here)NA27374176
OV_576AlphavirusM1RNATogaviridaeNoneNoViral strain in combination with H89(10 μM) for 1 hourNoATCCHuman colorectal carcinoma cell lineHCT-1164000 cells per wellVery small toxicity towards human immortalized liver cell line L-02MTT assay0.1 PFU/cell22% cancer cell viability at 72 hours post-infectionNoNoNA No responseNAJNK, mitochondrial apoptotic pathway, Caspase-3/7, Caspase-9 and Caspase-8 (active caspases activates downstream apoptotic pathway) are activatedM1 upregulated transcriptional ISGs (329 shown here) were inhibited by H89NA27374176
OV_577AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman colorectal carcinoma cell lineHCT-1164000 cells per wellNon toxic to human immortalized liver cell line L-02MTT assay0.1 PFU/cell92% cancer cell viability at 72 hours post-infectionNoNoNA No responseNANAM1 upregulated transcriptional ISGs (329 shown here)NA27374176
OV_578AlphavirusM1RNATogaviridaeNoneNoViral strain in combination with H89(10 μM) for 1 hourNoATCCHuman colorectal carcinoma cell lineHCT-1164000 cells per wellVery small toxicity towards human immortalized liver cell line L-02MTT assay1 PFU/cell20% cancer cell viability at 72 hours post-infectionNoNoNA No responseNAJNK, mitochondrial apoptotic pathway, Caspase-3/7, Caspase-9 and Caspase-8 (active caspases activates downstream apoptotic pathway) are activatedM1 upregulated transcriptional ISGs (329 shown here) were inhibited by H89NA27374176
OV_579AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman colorectal carcinoma cell lineHCT-1164000 cells per wellNon toxic to human immortalized liver cell line L-02MTT assay1 PFU/cell80% cancer cell viability at 72 hours post-infectionNoNoNA No responseNANAM1 upregulated transcriptional ISGs (329 shown here)NA27374176
OV_580AlphavirusM1RNATogaviridaeNoneNoViral strain in combination with H89(10 μM) for 1 hourNoATCCHuman colorectal carcinoma cell lineHCT-1164000 cells per wellVery small toxicity towards human immortalized liver cell line L-02MTT assay10 PFU/cell20% cancer cell viability at 72 hours post-infectionNoNoNA No responseNAJNK, mitochondrial apoptotic pathway, Caspase-3/7, Caspase-9 and Caspase-8 (active caspases activates downstream apoptotic pathway) are activatedM1 upregulated transcriptional ISGs (329 shown here) were inhibited by H89NA27374176
OV_581AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman colorectal carcinoma cell lineHCT-1164000 cells per wellNon toxic to human immortalized liver cell line L-02MTT assay10 PFU/cell75% cancer cell viability at 72 hours post-infectionNoNoNA No responseNANAM1 upregulated transcriptional ISGs (329 shown here)NA27374176
OV_592AlphavirusM1RNATogaviridaeNoneNoViral strain in combination with small interfering RNA (siRNAs) against Epac1 (siEpac1001)NoATCCHuman colorectal carcinoma cell lineHCT-1164000 cells per wellVery small toxicity towards human immortalized liver cell line L-02MTT assay10 PFU/cell100% cancer cell viability at 72 hours post-infectionNoNoNA No responseNANAM1 upregulated transcriptional ISGs (329 shown here)NA27374176
OV_593AlphavirusM1RNATogaviridaeNoneNoViral strain in combination with small interfering RNA (siRNAs) against Epac1 (siEpac1002)NoATCCHuman colorectal carcinoma cell lineHCT-1164000 cells per wellVery small toxicity towards human immortalized liver cell line L-02MTT assay10 PFU/cell70% cancer cell viability at 72 hours post-infectionNoNoNA No responseNANAM1 upregulated transcriptional ISGs (329 shown here)NA27374176
OV_594AlphavirusM1RNATogaviridaeNoneNoViral strain in combination with small interfering RNA (siRNAs) against Epac1 (siEpac1003)NoATCCHuman colorectal carcinoma cell lineHCT-1164000 cells per wellVery small toxicity towards human immortalized liver cell line L-02MTT assay10 PFU/cell90% cancer cell viability at 72 hours post-infectionNoNoNA No responseNANAM1 upregulated transcriptional ISGs (329 shown here)NA27374176
OV_595AlphavirusM1RNATogaviridaeNoneNoViral strain in combination with small interfering RNA (siRNAs) against Epac1 (siEpac1001) and with H89(10 μM)NoATCCHuman colorectal carcinoma cell lineHCT-1164000 cells per wellVery small toxicity towards human immortalized liver cell line L-02MTT assay10 PFU/cell60% cancer cell viability at 72 hours post-infectionNoNoNA No responseNAJNK, mitochondrial apoptotic pathway, Caspase-3/7, Caspase-9 and Caspase-8 (active caspases activates downstream apoptotic pathway) are activatedM1 upregulated transcriptional ISGs (329 shown here) were inhibited by H89NA27374176
OV_596AlphavirusM1RNATogaviridaeNoneNoViral strain in combination with small interfering RNA (siRNAs) against Epac1 (siEpac1002) and with H89(10 μM)NoATCCHuman colorectal carcinoma cell lineHCT-1164000 cells per wellVery small toxicity towards human immortalized liver cell line L-02MTT assay10 PFU/cell45% cancer cell viability at 72 hours post-infectionNoNoNA No responseNAJNK, mitochondrial apoptotic pathway, Caspase-3/7, Caspase-9 and Caspase-8 (active caspases activates downstream apoptotic pathway) are activatedM1 upregulated transcriptional ISGs (329 shown here) were inhibited by H89NA27374176
OV_597AlphavirusM1RNATogaviridaeNoneNoViral strain in combination with small interfering RNA (siRNAs) against Epac1 (siEpac1003) and with H89(10 μM)NoATCCHuman colorectal carcinoma cell lineHCT-1164000 cells per wellVery small toxicity towards human immortalized liver cell line L-02MTT assay10 PFU/cell75% cancer cell viability at 72 hours post-infectionNoNoNA No responseNAJNK, mitochondrial apoptotic pathway, Caspase-3/7, Caspase-9 and Caspase-8 (active caspases activates downstream apoptotic pathway) are activatedM1 upregulated transcriptional ISGs (329 shown here) were inhibited by H89NA27374176
OV_598AlphavirusM1RNATogaviridaeNoneNoViral strain in combination with ESI-09 and with H89(10 μM)NoATCCHuman colorectal carcinoma cell lineHCT-1164000 cells per wellNAMTT assay0.1 PFU/cell60% cancer cell viability at 72 hours post-infectionNoNoNA No responseNAESI-09 abrogates the activities of Caspase-3/9/8 induced by H89/M1 combination treatment.M1 upregulated transcriptional ISGs (329 shown here) were inhibited by H89NA27374176
OV_599AlphavirusM1RNATogaviridaeNoneNoViral strain in combination with ESI-09NoATCCHuman colorectal carcinoma cell lineHCT-1164000 cells per wellNAMTT assay0.1 PFU/cell80% cancer cell viability at 72 hours post-infectionNoNoNA No responseNAESI-09 abrogates the activities of Caspase-3/9/8 induced by H89/M1 combination treatment.M1 upregulated transcriptional ISGs (329 shown here)NA27374176
OV_1156Herpes simplex virusNV1020DNAHerpesviridaeNoneYesNoNoATCCColon carcinoma cell lineHCT-1161.25E+3 cells per wellNAWST-1 assay1 × 10⁶ pfu/ml70% cell killingNoNoNA No responseNANANANA17117895
OV_2760AdenovirusZD55-lipocalin2DNAAdenoviridaeDeletion of E1B55 gene and insertion of lipocalin2 geneYesNoNoShanghai cell collectionHuman colorectal cancer cell lineHCT-116NANAMTT assay0.01 MOINo cell deathNoNoNA No responseNAInducing apoptosis and decreasing microvessel density of tumorNANA23464854
OV_2761AdenovirusZD55-lipocalin2DNAAdenoviridaeDeletion of E1B55 gene and insertion of lipocalin2 geneYesNoNoShanghai cell collectionHuman colorectal cancer cell lineHCT-116NANAMTT assay0.5 MOIModerate cell deathNoNoNA No responseNAInducing apoptosis and decreasing microvessel density of tumorNANA23464854
OV_2762AdenovirusZD55-lipocalin2DNAAdenoviridaeDeletion of E1B55 gene and insertion of lipocalin2 geneYesNoNoShanghai cell collectionHuman colorectal cancer cell lineHCT-116NANAMTT assay1 MOIModerate cell deathNoNoNA No responseNAInducing apoptosis and decreasing microvessel density of tumorNANA23464854
OV_2763AdenovirusZD55-lipocalin2DNAAdenoviridaeDeletion of E1B55 gene and insertion of lipocalin2 geneYesNoNoShanghai cell collectionHuman colorectal cancer cell lineHCT-116NANAMTT assay10 MOIAll cells are diedNoNoNA No responseNAInducing apoptosis and decreasing microvessel density of tumorNANA23464854
OV_2819Vaccinia viruswild typeDNAPoxviridaeNoneYesNoNoATCCHuman colorectal cancer cell lineHCT-1161.0E+6 cells per wellNAMTT assay0.1 MOI100% cell survival after 24 hoursNoNoNA No responseNANAUpregulation of immune related antigens and cytokines like IFN-gamma, IP-10, MCP-1, MCP-3NA23531320
OV_2820Vaccinia viruswild typeDNAPoxviridaeNoneYesNoNoATCCHuman colorectal cancer cell lineHCT-1161.0E+6 cells per wellNAMTT assay0.1 MOI20% cell survival after 48 hoursNoNoNA No responseNANAUpregulation of immune related antigens and cytokines like IFN-gamma, IP-10, MCP-1, MCP-3NA23531320
OV_2821Vaccinia viruswild typeDNAPoxviridaeNoneYesNoNoATCCHuman colorectal cancer cell lineHCT-1161.0E+6 cells per wellNAMTT assay0.1 MOI20% cell survival after 72 hoursNoNoNA No responseNANAUpregulation of immune related antigens and cytokines like IFN-gamma, IP-10, MCP-1, MCP-3NA23531320
OV_2834Vaccinia viruswild typeDNAPoxviridaeNoneYesNoNoATCCHuman colorectal cancer cell lineHCT-1161.0E+6 cells per wellNAMTT assay1 MOI60% cell survival after 24 hoursNoNoNA No responseNANAUpregulation of immune related antigens and cytokines like IFN-gamma, IP-10, MCP-1, MCP-3NA23531320
OV_2835Vaccinia viruswild typeDNAPoxviridaeNoneYesNoNoATCCHuman colorectal cancer cell lineHCT-1161.0E+6 cells per wellNAMTT assay1 MOI40% cell survival after 48 hoursNoNoNA No responseNANAUpregulation of immune related antigens and cytokines like IFN-gamma, IP-10, MCP-1, MCP-3NA23531320
OV_2836Vaccinia viruswild typeDNAPoxviridaeNoneYesNoNoATCCHuman colorectal cancer cell lineHCT-1161.0E+6 cells per wellNAMTT assay1 MOI100% cell death after 72 hoursNoNoNA No responseNANAUpregulation of immune related antigens and cytokines like IFN-gamma, IP-10, MCP-1, MCP-3NA23531320
OV_2843Vaccinia viruswild typeDNAPoxviridaeNoneYesNoNoATCCHuman colorectal cancer cell lineHCT-116NANANANANAHsd:athymic nude mice xenograft for HCT-116 (5.0E+6 cells)5.0E+6 pfuNA Significant reduction in tumor volume after 42 daysIntratumoralNANANA23531320
OV_2972TanapoxvirusTPV-delta66R-mMCP-1DNAPoxviridaeDeletion of 66R and insertion of MCP-1 geneYesNoNoATCCHuman colorectal cancer cell lineHCT-116NANANANANANude Foxn1 mice xenograft for HCT-116 (5.0E+6)5.0E+6 pfuNA Reduction in tumor volume to 50mm after 36 daysIntratumoralNATriggers activation of Ipaf inflamosome, IL-beta, TNF-alpha, IL-6 and IL-8NA25887490
OV_2973TanapoxvirusTPV-delta66R/flicDNAPoxviridaeDeletion of 66R and insertion of flic geneYesNoNoATCCHuman colorectal cancer cell lineHCT-116NANANANANANude Foxn1 mice xenograft for HCT-116 (5.0E+6)5 × 10⁶ pfu NA Reduction in tumor volume to below 50mm after 36 daysIntratumoralNATriggers activation of Ipaf inflamosome, IL-beta, TNF-alpha, IL-6 and IL-8NA25887490
OV_2974TanapoxvirusTPV-delta66RDNAPoxviridaeDeletion of 66RYesNoNoATCCHuman colorectal cancer cell lineHCT-116NANANANANANude Foxn1 mice xenograft for HCT-116 (5.0E+6)5 × 10⁶ pfu NA Reduction in tumor volume to 50mm after 36 daysIntratumoralNATriggers activation of Ipaf inflamosome, IL-beta, TNF-alpha, IL-6 and IL-8NA25887490
OV_2975TanapoxvirusTPV-delta2LDNAPoxviridaeDeletion of 2L geneYesNoNoATCCHuman colorectal cancer cell lineHCT-116NANANANANANude Foxn1 mice xenograft for HCT-116 (5.0E+6)5 × 10⁶ pfu NA Reduction in tumor volume to below 50mm after 36 daysIntratumoralNATriggers activation of Ipaf inflamosome, IL-beta, TNF-alpha, IL-6 and IL-8NA25887490
OV_2976TanapoxvirusTPV-delta2L/delta66R/flicDNAPoxviridaeDeletion of 66R, 2L and insertion of flic geneYesNoNoATCCHuman colorectal cancer cell lineHCT-116NANANANANANude Foxn1 mice xenograft for HCT-116 (5.0E+6)5 × 10⁶ pfu NA Reduction in tumor volume to below 50mm after 36 daysIntratumoralNATriggers activation of Ipaf inflamosome, IL-beta, TNF-alpha, IL-6 and IL-8NA25887490
OV_2982PoxvirusCF33-hNISDNAPoxviridaeInsertion of gene encoding human hNISYesNoNoATCCHuman colorectal cancer cell lineHCT-1163.0E+3 cells per wellNACell viability assay kit0.01 MOI100% cell survival after 24 hoursNoNoNA No responseNAImmunogenicity followed by virus induced cell deathNANA31061881
OV_2983PoxvirusCF33-hNISDNAPoxviridaeInsertion of gene encoding human hNISYesNoNoATCCHuman colorectal cancer cell lineHCT-1163.0E+3 cells per wellNACell viability assay kit0.01 MOI98% cell survival after 48 hoursNoNoNA No responseNAImmunogenicity followed by virus induced cell deathNANA31061881
OV_2984PoxvirusCF33-hNISDNAPoxviridaeInsertion of gene encoding human hNISYesNoNoATCCHuman colorectal cancer cell lineHCT-1163.0E+3 cells per wellNACell viability assay kit0.01 MOI80% cell survival after 72 hoursNoNoNA No responseNAImmunogenicity followed by virus induced cell deathNANA31061881
OV_2985PoxvirusCF33-hNISDNAPoxviridaeInsertion of gene encoding human hNISYesNoNoATCCHuman colorectal cancer cell lineHCT-1163.0E+3 cells per wellNACell viability assay kit0.01 MOI45% cell survival after 96 hoursNoNoNA No responseNAImmunogenicity followed by virus induced cell deathNANA31061881
OV_2986PoxvirusCF33-hNISDNAPoxviridaeInsertion of gene encoding human hNISYesNoNoATCCHuman colorectal cancer cell lineHCT-1163.0E+3 cells per wellNACell viability assay kit0.01 MOI5% cell survival after 120 hoursNoNoNA No responseNAImmunogenicity followed by virus induced cell deathNANA31061881
OV_2987PoxvirusCF33-hNISDNAPoxviridaeInsertion of gene encoding human hNISYesNoNoATCCHuman colorectal cancer cell lineHCT-1163.0E+3 cells per wellNACell viability assay kit1 MOI80% cell survival after 24 hoursNoNoNA No responseNAImmunogenicity followed by virus induced cell deathNANA31061881
OV_2988PoxvirusCF33-hNISDNAPoxviridaeInsertion of gene encoding human hNISYesNoNoATCCHuman colorectal cancer cell lineHCT-1163.0E+3 cells per wellNACell viability assay kit1 MOI30% cell survival after 48 hoursNoNoNA No responseNAImmunogenicity followed by virus induced cell deathNANA31061881
OV_2989PoxvirusCF33-hNISDNAPoxviridaeInsertion of gene encoding human hNISYesNoNoATCCHuman colorectal cancer cell lineHCT-1163.0E+3 cells per wellNACell viability assay kit1 MOI20% cell survival after 72 hoursNoNoNA No responseNAImmunogenicity followed by virus induced cell deathNANA31061881
OV_2990PoxvirusCF33-hNISDNAPoxviridaeInsertion of gene encoding human hNISYesNoNoATCCHuman colorectal cancer cell lineHCT-1163.0E+3 cells per wellNACell viability assay kit1 MOI5% cell survival after 96 hoursNoNoNA No responseNAImmunogenicity followed by virus induced cell deathNANA31061881
OV_2991PoxvirusCF33-hNISDNAPoxviridaeInsertion of gene encoding human hNISYesNoNoATCCHuman colorectal cancer cell lineHCT-1163.0E+3 cells per wellNACell viability assay kit1 MOI100% cell death after 120 hoursNoNoNA No responseNAImmunogenicity followed by virus induced cell deathNANA31061881
OV_3002PoxvirusCF33-hNISDNAPoxviridaeInsertion of gene encoding human hNISYesNoNoATCCHuman colorectal cancer cell lineHCT-116NANANANANAHsd:athymic nude mice xenograft for HCT-116 (2.0E+6 cells)1.0E+5 pfuNA Complete regression in tumor volume after 55 daysIntratumoralImmunogenicity followed by virus induced cell deathNANA31061881
OV_3004PoxvirusCF33-hNISDNAPoxviridaeInsertion of gene encoding human hNISNoVirus in combination with I-131NoATCCHuman colorectal cancer cell lineHCT-116NANANANANAHsd:athymic nude mice xenograft for HCT-116 (2.0E+6 cells)1.0E+4 pfuNA Reduction in tumor volume below 100mm after 55 daysIntravenousImmunogenicity followed by virus induced cell deathNANA31061881
OV_3072Vaccinia virusDeltaJ2R/FCU1 VACVDNAPoxviridaeDeletion of J2R gene and insertion of gene FCU1YesNoNoATCCHuman colon cancer cell lineHCT-1163.0E+5 cells per wellNATrypan blue assay10⁻⁴ MOI30% cell viabilityNoNoNA No responseNANANANA31011628
OV_3073Vaccinia virusDeltaJ2R/FCU1 VACVDNAPoxviridaeDeletion of J2R gene and insertion of gene FCU1YesNoNoATCCHuman colon cancer cell lineHCT-1163.0E+5 cells per wellNATrypan blue assay10⁻³ MOI5% cell viabilityNoNoNA No responseNANANANA31011628
OV_3074Vaccinia virusDeltaJ2R/FCU1 VACVDNAPoxviridaeDeletion of J2R gene and insertion of gene FCU1YesNoNoATCCHuman colon cancer cell lineHCT-1163.0E+5 cells per wellNATrypan blue assay10⁻² MOI1% cell viabilityNoNoNA No responseNANANANA31011628
OV_3102Vaccinia virusDeltaJ2R-I4L/FCU1 VACV (TG6002)DNAPoxviridaeDeletion of J2R and I4L gene and insertion of gene FCU1YesNoNoATCCHuman colon cancer cell lineHCT-1163.0E+5 cells per wellNATrypan blue assay10⁻⁴ MOI30% cell viabilityNoNoNA No responseNANANANA31011628
OV_3103Vaccinia virusDeltaJ2R-I4L/FCU1 VACV (TG6002)DNAPoxviridaeDeletion of J2R and I4L gene and insertion of gene FCU1YesNoNoATCCHuman colon cancer cell lineHCT-1163.0E+5 cells per wellNATrypan blue assay10⁻³ MOI10% cell viabilityNoNoNA No responseNANANANA31011628
OV_3104Vaccinia virusDeltaJ2R-I4L/FCU1 VACV (TG6002)DNAPoxviridaeDeletion of J2R and I4L gene and insertion of gene FCU1YesNoNoATCCHuman colon cancer cell lineHCT-1163.0E+5 cells per wellNATrypan blue assay10⁻² MOI1% cell deathNoNoNA No responseNANANANA31011628
OV_3117Vaccinia virusVaccinia virus deltaJ2R/FCU1 VACVDNAPoxviridaeDeletion of J2R gene and insertion of gene FCU1NoVirus strain in combination with 5-FC (200mg/kg)NoATCCHuman colon cancer cell lineHCT-116NANANANANABD62 mice xenograft for Lovo cell line1.0E+7 pfuNA Tumor volume decreases to below 500 mm after 50 daysIntravenousNANANA31011628
OV_3118Vaccinia virusDeltaJ2R-I4L/FCU1 VACV (TG6002)DNAPoxviridaeDeletion of J2R and I4L gene and insertion of gene FCU1NoVirus strain in combination with 5-FC (200mg/kg)NoATCCHuman colon cancer cell lineHCT-116NANANANANABD62 mice xenograft for Lovo cell line1.0E+7 pfuNA Tumor volume decreases to below 100 mm after 50 daysIntravenousNANANA31011628
OV_3675Measles viruswild typeRNAParamyxoviridaeNoneYesNoNoATCCHuman colon cancer cell lineHCT-1165000 cells per wellNAMTT assay1 MOI80% cell viability after day 3NoNoNA No responseNAVirus in combination with induce apiptosis in cancer cellNANA29485292
OV_3676Measles viruswild typeRNAParamyxoviridaeNoneYesNoNoATCCHuman colon cancer cell lineHCT-1165000 cells per wellNAMTT assay1 MOI70% cell viability after day 6NoNoNA No responseNAVirus in combination with induce apiptosis in cancer cellNANA29485292
OV_3691Mumps viruswild typeRNAParamyxoviridaeNoneYesNoNoATCCHuman colon cancer cell lineHCT-1165000 cells per wellNAMTT assay1 MOI80% cell viability after day 3NoNoNA No responseNAVirus in combination with induce apiptosis in cancer cellNANA29485292
OV_3692Mumps viruswild typeRNAParamyxoviridaeNoneYesNoNoATCCHuman colon cancer cell lineHCT-1165000 cells per wellNAMTT assay1 MOI75% cell viability after day 6NoNoNA No responseNAVirus in combination with induce apiptosis in cancer cellNANA29485292
OV_3707Measles and mumps viruswild typeRNAParamyxoviridaeNoneNoMeasles virus in combination with mumps virusNoATCCHuman colon cancer cell lineHCT-1165000 cells per wellNAMTT assay1 MOI80% cell viability after day 3NoNoNA No responseNAVirus in combination with induce apiptosis in cancer cellNANA29485292
OV_3708Measles and mumps viruswild typeRNAParamyxoviridaeNoneNoMeasles virus in combination with mumps virusNoATCCHuman colon cancer cell lineHCT-1165000 cells per wellNAMTT assay1 MOI50% cell viability after day 6NoNoNA No responseNAVirus in combination with induce apiptosis in cancer cellNANA29485292
OV_3775Newcastle disease virusNDVstrain 852RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay16 HAU30% cells viability after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3776Newcastle disease virusNDVstrain 770RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay16 HAU38% cells viability after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3777Newcastle disease virusNDVstrain 320RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay16 HAU44% cells viability after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3778Newcastle disease virusNDVstrain 373RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay16 HAU55% cells viability after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3779Newcastle disease virusNDVstrain 321RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay16 HAU58% cells viability after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3780Newcastle disease virusNDVstrain 264RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay16 HAU58% cells viability after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3781Newcastle disease virusNDVstrain 776RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay16 HAU62% cells viability after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3782Newcastle disease virusNDVstrain 880RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay16 HAU65% cells viability after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3783Newcastle disease virusNDVstrain 14RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay16 HAU70% cells viability after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3784Newcastle disease virusNDVstrain 329RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay16 HAU70% cells viability after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3785Newcastle disease virusNDVstrain 485RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay16 HAU80% cells viability after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3786Newcastle disease virusNDVstrain 718RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay16 HAU82% cells viability after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3787Newcastle disease virusNDVstrain 53RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay16 HAU85% cells viability after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3788Newcastle disease virusNDVstrain 52RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay16 HAU85% cells viability after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3789Newcastle disease virusNDVstrain 746RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay16 HAU85% cells viability after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3790Newcastle disease virusNDVstrain 12RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay16 HAU85% cells viability after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3791Newcastle disease virusNDVstrain 49RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay16 HAU90% cells viability after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3792Newcastle disease virusNDVstrain 753RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay16 HAU90% cells viability after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3793Newcastle disease virusNDVstrain 777RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay16 HAU95% cells viability after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3794Newcastle disease virusNDVstrain 789RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay16 HAU95% cells viability after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3795Newcastle disease virusNDVstrain 27RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay16 HAU95% cells viability after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3796Newcastle disease virusNDVstrain 48RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay16 HAU100% cell viability after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3797Newcastle disease virusNDVstrain 389RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay16 HAU100% cell viability after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3798Newcastle disease virusNDVstrain ADRNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay16 HAU100% cell viability after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3799Newcastle disease virusNDVstrain 922RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay16 HAU100% cell viability after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3800Newcastle disease virusNDVstrain 945RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay16 HAU100% cell viability after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3801Newcastle disease virusNDVstrain 429RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay16 HAU100% cell viability after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3802Newcastle disease virusNDVstrain 339RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay16 HAU100% cell viability after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3887Newcastle disease virusNDVstrain 264RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay2 HAU63% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3888Newcastle disease virusNDVstrain 264RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay8 HAU60% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3889Newcastle disease virusNDVstrain 264RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay16 HAU58% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3890Newcastle disease virusNDVstrain 320RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay2 HAU69% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3891Newcastle disease virusNDVstrain 320RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay8 HAU55% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3892Newcastle disease virusNDVstrain 320RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay16 HAU43% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3893Newcastle disease virusNDVstrain 321RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay2 HAU75% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3894Newcastle disease virusNDVstrain 321RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay8 HAU67% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3895Newcastle disease virusNDVstrain 321RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay16 HAU58% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3896Newcastle disease virusNDVstrain 373RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay2 HAU64% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3897Newcastle disease virusNDVstrain 373RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay8 HAU59% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3898Newcastle disease virusNDVstrain 373RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay16 HAU54% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3899Newcastle disease virusNDVstrain 770RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay2 HAU57% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3900Newcastle disease virusNDVstrain 770RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay8 HAU41% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3901Newcastle disease virusNDVstrain 770RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay16 HAU37% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3902Newcastle disease virusNDVstrain 852RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay2 HAU37% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3903Newcastle disease virusNDVstrain 852RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay8 HAU32% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3904Newcastle disease virusNDVstrain 852RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay16 HAU29% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3905Newcastle disease virusNDVstrain 776RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay2 HAU68% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3906Newcastle disease virusNDVstrain 776RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay8 HAU65% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3907Newcastle disease virusNDVstrain 776RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay16 HAU62% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3992Newcastle disease virusNDVwild 264RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay2 HAU62% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3993Newcastle disease virusNDVwild 264RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay8 HAU60% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_3994Newcastle disease virusNDVwild 264RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay16 HAU58% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4004Newcastle disease virusNDVwild 320RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay2 HAU70% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4005Newcastle disease virusNDVwild 320RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay8 HAU58% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4006Newcastle disease virusNDVwild 320RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay16 HAU42% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4016Newcastle disease virusNDVwild 321RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay2 HAU70% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4017Newcastle disease virusNDVwild 321RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay8 HAU65% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4018Newcastle disease virusNDVwild 321RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay16 HAU58% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4028Newcastle disease virusNDVwild 373RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay2 HAU62% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4029Newcastle disease virusNDVwild 373RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay8 HAU60% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4030Newcastle disease virusNDVwild 373RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay16 HAU58% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4040Newcastle disease virusNDVwild 770RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay2 HAU50% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4041Newcastle disease virusNDVwild 770RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay8 HAU42% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4042Newcastle disease virusNDVwild 770RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay16 HAU38% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4052Newcastle disease virusNDVwild 852RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay2 HAU38% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4053Newcastle disease virusNDVwild 852RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay8 HAU35% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4054Newcastle disease virusNDVwild 852RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay16 HAU30% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4064Newcastle disease virusNDVwild 776RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay2 HAU68% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4065Newcastle disease virusNDVwild 776RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay8 HAU65% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4066Newcastle disease virusNDVwild 776RNAParamyxoviridaeNoneYesNoNoState centre for virology and biotechnology, RussiaHuman colon carcinoma cell lineHCT-11610000 cells per wellNAMTT assay16 HAU62% cell survival after 4th dayNoNoNA No responseNAVirus induces apoptosis, necrosis and autophagy in cancer cellsInduction of MARK signalling pathwayNA29621357
OV_4313AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman colorectal carcinomaHCT-1164000 cells per wellNAMTT assay10 pfu81.3 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4343AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman colorectal carcinomaHCT-1164000 cells per wellNAMTT assay0.001 MOI100% cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4344AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman colorectal carcinomaHCT-1164000 cells per wellNAMTT assay0.01 MOI100% cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4345AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman colorectal carcinomaHCT-1164000 cells per wellNAMTT assay0.1 MOI100% cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4346AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman colorectal carcinomaHCT-1164000 cells per wellNAMTT assay10 MOI100% cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4347AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman colorectal carcinomaHCT-1164000 cells per wellNAMTT assay100 MOI90% cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4348AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman colorectal carcinomaHCT-1164000 cells per wellNAMTT assay0.001 MOI100% cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4349AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman colorectal carcinomaHCT-1164000 cells per wellNAMTT assay0.01 MOI100% cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4350AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman colorectal carcinomaHCT-1164000 cells per wellNAMTT assay0.1 MOI100% cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4351AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman colorectal carcinomaHCT-1164000 cells per wellNAMTT assay10 MOI100% cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4352AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman colorectal carcinomaHCT-1164000 cells per wellNAMTT assay100 MOI100% cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4358AlphavirusM1RNATogaviridaeNoneNoVirus in combination with dbcAMP 100 micromoalrNoATCCHuman colorectal carcinomaHCT-1164000 cells per wellNAMTT assay0.001 MOI40% cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4359AlphavirusM1RNATogaviridaeNoneNoVirus in combination with dbcAMP 200 micromoalrNoATCCHuman colorectal carcinomaHCT-1164000 cells per wellNAMTT assay0.01 MOI30% cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4360AlphavirusM1RNATogaviridaeNoneNoVirus in combination with dbcAMP 400 micromoalrNoATCCHuman colorectal carcinomaHCT-1164000 cells per wellNAMTT assay0.1 MOI30% cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_5069Avian orthoreovirusARV-PB1RNAReoviridaeNoneYesNoNoATCCHuman colorectal cancer cell lineHCT-1161.0E+3 cells per wellNACrystal violet staining10 MOI100% cell viability after 96 hoursNoNoNA No responseNAInduction of apoptosisInduction of Interferon related gene expressionNA28441762